Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1

Clinical trial NCT02323529 · COMPLETED

Trial details

NCT number: NCT02323529
Sponsor: Swedish Orphan Biovitrum
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Tyrosinemia, Type I

Start date: 2014-12-01
Primary completion: 2015-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.